Luis
Madero Lopez
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (8)
2021
2020
-
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042
2016
-
Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells
Cancer Letters, Vol. 371, Núm. 2, pp. 161-170
2015
-
Chemokines and relapses in childhood acute lymphoblastic leukemia: A role in migration and in resistance to antileukemic drugs
Blood Cells, Molecules, and Diseases, Vol. 55, Núm. 3, pp. 220-227
2013
-
A role for the CXCR3/CXCL10 axis in rasmussen encephalitis
Pediatric Neurology, Vol. 49, Núm. 6, pp. 451-457.e1
2011
-
Chromosome fragility in patients with Fanconi anaemia: Diagnostic implications and clinical impact
Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 242-250
-
Origin, functional role, and clinical impact of fanconi anemia fanca mutations
Blood, Vol. 117, Núm. 14, pp. 3759-3769
2002
-
Complex cytogenetic abnormalities including telomeric associations and MEN1 mutation in a pediatric ependymoma
Cancer Genetics and Cytogenetics, Vol. 138, Núm. 2, pp. 107-110